Nonin Medical partners with Medixine to co-develop remote digital monitoring services for more patient-centric diagnoses of chronic conditions. Summary: Nonin Medical partners with Medixine to introduce remote patient monitoring for its pulse oximetry devices, aiming to improve care for chronic conditions. The collaboration addresses the growing demand for digital health solutions, particularly in the US. The integration of Medixine’s software platform with Nonin’s pulse oximeters aims to enhance accessibility to patient data for clinicians, streamlining diagnosis and treatment. By digitizing ..read more

Improved cognitive performance was seen after a high single dose of creatine. Researchers say the sports supplement could become a “serious competitor” to coffee if its effects can be proven at low doses.  Summary: A study reveals that a high single dose of creatine, a popular sports supplement, can temporarily enhance cognitive performance during sleep deprivation. Fifteen subjects underwent cognitive tasks after staying awake overnight, showing improved processing capacity and short-term memory after ingesting creatine. The study indicates that creatine’s effects peak after four hours a ..read more

Canadian employees are facing challenges with sleep and physical activity, with these issues driving lower wellness scores compared to pre-pandemic levels. Summary: A new report reveals that Canadians are struggling with sleep and physical activity, which is impacting their overall well-being. The Well-Being Report uses the WHO-5 Well-Being Index to assess mental health and lifestyle dimensions monthly. Findings indicate particularly low scores in sleep and exercise, exacerbated by stress from work, family, and financial pressures. The report emphasizes the importance of small, manageable dail ..read more

Recent findings suggest that higher levels of light exposure could improve alertness and cognitive abilities, potentially offering new avenues for light therapy treatments aimed at boosting sleep quality and mental performance. Summary: New research suggests that exposure to higher light levels can enhance wakefulness and cognitive performance by influencing the hypothalamus, a brain region associated with sleep and alertness. The study, involving 26 young adults, used 7 Tesla MRI to show that light exposure boosts hypothalamus activity, correlating with improved task performance. This insight ..read more

The phase 2 clinical trial will evaluate the safety and efficacy of ALKS 2680, an oral treatment designed to address orexin signaling deficiencies in patients with narcolepsy type 1. Summary: Alkermes plc has launched the Vibrance-1 study, a phase 2 clinical trial to assess the safety and efficacy of ALKS 2680, a novel orexin-2 receptor agonist, in treating narcolepsy type 1. This oral treatment aims to improve wakefulness by targeting the orexin system, which is often deficient in narcolepsy patients. The double-blind, placebo-controlled study will test three dosages over six weeks across mul ..read more

The dos and don’ts of enrolling sleep patients in revenue-producing RPM programs. By Sree Roy Clinical sleep medicine programs have long relied on testing and treatment reimbursement codes as major contributors to their financial bottom line. But as those revenues dwindle, remote patient monitoring (RPM) can add reimbursement streams that promote longitudinal care and pay for the CPAP troubleshooting that sleep clinicians are already doing. “As the sleep industry undergoes transformation, we see RPM as the catalyst for clinicians to evolve,” says Edward Mezerhane, MD, FAASM, FACP, medical dire ..read more

SleepCogni will collaborate with Sheffield Children’s NHS Foundation Trust to advance its handheld insomnia devices for use in young patients. Summary: SleepCogni has received over £340,000 in Innovate UK grant funding to collaborate with Sheffield Children’s NHS Foundation Trust on addressing insomnia in children and young people. SleepCogni’s handheld devices use vibration, light, and sound to disrupt the cognitive cycles that prevent sleep, while also collecting data to analyze sleep disturbances. This partnership follows a successful trial that significantly reduced insomnia symptoms in ad ..read more

Remedē is implanted under the skin in the upper chest and stimulates the phrenic nerve to regulate breathing. Summary: Allegheny Health Network has implanted the remedē device, a pacemaker-like system for treating central sleep apnea. The device, which stimulates the diaphragm with electrical currents to restore normal breathing, offers an alternative to CPAP systems. Implanted by a cardiac electrophysiologist, remedē has shown to improve patients’ quality of life and reduce daytime sleepiness in a clinical study. This collaboration between the Allegheny Health Network Sleep Medicine Center an ..read more

The Stellar Sleep app now features extended CBT-I programming and integrations with Fitbit, Oura Ring, and Apple Health. Summary: Stellar Sleep has upgraded its app to enhance chronic insomnia management, incorporating new features for better sleep tracking and expanded content access. The app employs cognitive behavioral therapy for insomnia (CBT-I). New additions include extended programming from five to 10 weeks, bookmarking for favorite lessons, a redesigned sleep center, and integrations with Fitbit, Oura Ring, and other devices. Launched in 2023 by George Wang, who overcame his own insom ..read more

Participants report improved sleep efficiency and quality with nightly use of hemp-derived gummies. Summary: Balanced Health Botanicals’ CBDistillery conducted a 31-day Pathfinder study using MoreBetter’s technology to assess the impact of their shhh+ Distilled THC + CBN Deep Sleep Gummies on sleep quality. The study found that participants experienced improved sleep quality, ease in falling back asleep, and woke up feeling more refreshed. Positive feedback was high, with 98% reporting a better quality of life and 77% preferring these gummies over other sleep aids. These findings have not been ..read more